Sponsor Pipeline

Liu Huang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06199895 Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the… Pancreatic Adenocarcinoma Recruiting
NCT07051785 Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as… Colorectal Cancer (CRC) Not Yet Recruiting
Phase 1/2
NCT06980532 Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein… Metastatic Colorectal Cancer Recruiting
Not specified
NCT06551207 Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line… Metastatic Colorectal Cancer Recruiting
NCT06413212 Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant… Lung Cancer Recruiting
NCT06985316 An Exploratory Clinical Study Evaluating the Efficacy and Safety of Tunlametinib Combined… CRC, Colorectal Cancer Not Yet Recruiting
Disease Areas
Colorectal Cancer (5) Lung Cancer (2) Breast Cancer (2) Gastric Cancer (2) Esophageal Cancer (1) Cholangiocarcinoma (1)
Get alerts when Liu Huang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free